Security
Cellectis S.A. American Depositary Shares · CLLS
CLLSNASDAQotherCurrentCIK 1627281Updated Oct 29, 2026
CLLS price & chart
Loading TradingView…
NASDAQ:CLLS on TradingView ↗In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
cash flow · annual statements
| Line item | Q4 2023 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Profit or LossUSD | — | -23,736,000Source | -25,270,000Source | -16,641,000Source | -19,454,000Source | -41,610,000Source | -35,852,000Source | -36,637,000Source | -67,593,000Source | -36,761,000Source | -108,443,000Source | -114,034,000Source |
| Additional Financial Items | ||||||||||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableUSD | — | — | — | — | — | — | — | — | — | 52,596,000Source | 2,252,000Source | -3,187,000Source |
| AdjustmentsForIncomeTaxExpenseUSD | — | — | — | — | — | — | — | — | -423,000Source | -539,000Source | 371,000Source | 87,000Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | — | — | — | — | — | — | — | — | — | 2,055,000Source | -6,305,000Source | 3,247,000Source |
| AdjustmentsForSharebasedPaymentsUSD | — | — | — | — | — | — | — | — | 6,110,000Source | 3,167,000Source | 5,233,000Source | 6,043,000Source |
| AdjustmentsForUnrealisedForeignExchangeLossesGainsUSD | — | — | — | — | — | — | — | — | — | — | — | -664,000Source |
| IncomeTaxesPaidRefundClassifiedAsOperatingActivitiesUSD | — | — | — | — | — | — | — | — | 5,000Source | — | — | — |
| IncreaseDecreaseInWorkingCapitalUSD | — | — | — | — | — | — | — | — | 41,593,000Source | -53,665,000Source | -48,859,000Source | 5,723,000Source |
| InterestPaidClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | — | 612,000Source | 847,000Source | 333,000Source | 332,000Source |
| InterestReceivedClassifiedAsOperatingActivitiesUSD | — | — | — | — | — | — | — | — | 8,428,000Source | 6,558,000Source | — | — |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | — | 10,814,000Source | 11,062,000Source | 11,084,000Source | 11,011,000Source |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | — | 0Source | 23,201,000Source | 29,671,000Source | — |
| ProceedsFromIssuingSharesUSD | — | — | — | — | — | — | — | — | — | — | — | -569,000Source |
| ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethodUSD | — | — | — | — | — | — | — | — | 133,669,000Source | 63,806,000Source | — | — |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | — | — | — | — | — | — | — | — | 1,173,000Source | 1,260,000Source | 0Source | 10,000Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | — | 5,379,000Source | 5,001,000Source | 5,107,000Source | — |
income statement · annual statements
| Line item | Q4 2023 | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | 5,078,000Source | 3,882,000Source | 3,950,000Source | 4,830,000Source | 9,343,000Source | 9,070,000Source | 11,818,000Source | 19,790,000Source | 19,085,000Source | 16,812,000Source | 17,494,000Source |
| Total RevenueUSD | — | 16,725,000Source | 8,061,000Source | 178,000Source | 1,307,000Source | 11,176,000Source | 2,900,000Source | 1,152,000Source | 72,949,000Source | 41,505,000Source | 755,000Source | 19,171,000Source |
| Additional Financial Items | ||||||||||||
| ApplicableTaxRatenumber | — | — | — | — | — | — | — | — | 0.25Source | 0.25Source | 0.25Source | 0.25Source |
| AverageEffectiveTaxRatenumber | — | 0Source | 0.01Source | -0.02Source | — | — | — | — | -0.01Source | 0Source | 0Source | 0Source |
| BasicEarningsLossPerShareUSD per share | — | -0.24Source | -0.28Source | -0.2Source | -0.42Source | -0.88Source | -0.76Source | -0.79Source | -0.67Source | -0.41Source | -1.77Source | -2.33Source |
| DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossUSD | — | — | — | — | — | — | — | — | -11,326,000Source | 10,742,000Source | 10,064,000Source | — |
| DepreciationRightofuseAssetsUSD | — | — | — | — | — | — | — | — | 7,509,000Source | — | — | 6,700,000Source |
| DilutedEarningsLossPerShareUSD per share | — | -0.24Source | -0.28Source | -0.2Source | -0.42Source | -0.88Source | -0.76Source | -0.79Source | -0.67Source | -0.41Source | -1.77Source | -2.33Source |
| FinanceCostsUSD | — | 19,695,000Source | 16,646,000Source | 16,284,000Source | 1,691,000Source | — | — | — | 51,064,000Source | 21,614,000Source | 40,642,000Source | 17,815,000Source |
| FinanceIncomeUSD | — | 5,545,000Source | 8,395,000Source | 10,440,000Source | 9,992,000Source | — | — | — | 16,124,000Source | 44,407,000Source | 21,479,000Source | 8,880,000Source |
| IncomeTaxExpenseContinuingOperationsUSD | — | 0Source | -193,000Source | 258,000Source | 0Source | 0Source | 0Source | — | -423,000Source | 0Source | 371,000Source | -87,000Source |
| InterestExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 371,000Source |
| InterestExpenseOnLeaseLiabilitiesUSD | — | 556,000Source | 663,000Source | 774,000Source | 863,000Source | — | — | — | 2,225,000Source | 2,636,000Source | 3,061,000Source | 3,416,000Source |
| NetForeignExchangeLossUSD | — | 17,400,000Source | 1,700,000Source | 1,289,000Source | 592,000Source | — | — | — | — | 5,754,000Source | 13,402,000Source | 1,481,000Source |
| OtherFinanceCostUSD | — | — | — | 0Source | 0Source | — | — | — | 0Source | 41,000Source | 1,121,000Source | 12,546,000Source |
| OtherIncomeUSD | — | 1,469,000Source | 1,442,000Source | 1,823,000Source | 1,416,000Source | 3,439,000Source | 1,716,000Source | 1,780,000Source | 6,644,000Source | 7,712,000Source | 8,438,000Source | 6,553,000Source |
| OtherOperatingIncomeExpenseUSD | — | 378,000Source | 686,000Source | 528,000Source | 753,000Source | 150,000Source | 111,000Source | -3,000Source | 638,000Source | 849,000Source | -1,300,000Source | 1,377,000Source |
| ProfitLossAttributableToNoncontrollingInterestsUSD | — | — | 0Source | -4,934,000Source | -506,000Source | -1,691,000Source | -3,589,000Source | -3,190,000Source | 0Source | 0Source | -7,384,000Source | -7,894,000Source |
| ProfitLossAttributableToOwnersOfParentUSD | — | -23,736,000Source | -25,270,000Source | -11,707,000Source | -18,946,000Source | -39,919,000Source | -32,263,000Source | -33,447,000Source | -67,593,000Source | -36,761,000Source | -101,059,000Source | -106,139,000Source |
| ProfitLossBeforeTaxUSD | — | — | -25,500,000Source | — | — | — | — | — | -68,016,000Source | -36,761,000Source | -116,464,000Source | -98,601,000Source |
| ProfitLossFromOperatingActivitiesUSD | — | -9,586,000Source | -17,211,000Source | -23,621,000Source | -27,313,000Source | -37,481,000Source | -33,031,000Source | -35,126,000Source | -33,076,000Source | -59,554,000Source | -97,302,000Source | -89,666,000Source |
| ResearchAndDevelopmentExpenseUSD | — | 23,080,000Source | 23,518,000Source | 22,200,000Source | 25,630,000Source | 31,147,000Source | 22,862,000Source | 25,421,000Source | 93,517,000Source | 90,536,000Source | 87,646,000Source | 97,501,000Source |
| RevenueFromInterestUSD | — | — | — | — | — | — | — | — | — | — | — | 1,120,000Source |
| DepreciationAndAmortisationExpense | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| EmployeeBenefitsExpense | — | —Source | —Source | — | — | — | — | — | — | — | — | — |
| ExpenseFromSharebasedPaymentTransactionsWithEmployees | — | —Source | —Source | — | — | — | — | — | — | — | — | — |
Filing attachments
clls-ex99_1.htm · 6-K/A · 2026-09-11
Exhibit 99.1 PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the six-month period ended June 30, 2026, included herein, have been prepared in accordance with International Accounting Standard 34 (“IAS 34”) - Interim Financial Reporting as issued by the International Accounting Standards Board (“IASB”). The consolidated financial statements are presented in U.S. dollars. All references in this interim report to “$” and “U.S. dollars” mean U.S. dollars and all refe…
Read attachment ↗clls-ex99_1.htm · S-8 · 2026-08-06
Exhibit 99.1 CELLECTIS 2026 STOCK OPTION PLAN CELLECTIS 2026 STOCK OPTION PLAN 1. Purposes of the Plan According to the authorization granted by the combined ordinary and extraordinary shareholders’ general meeting dated June 25, 2026, the board of directors decided on August 6, 2026, in compliance with the provisions of articles L. 225-177 et seq. of the French Commercial Code, to adopt the 2026 stock option plan of CELLECTIS, the terms and conditions of which are set out below. The purp…
Read attachment ↗clls-ex99_2.htm · S-8 · 2026-08-06
Exhibit 99.2 CELLECTIS 2026 Free Shares Plan Approved by the Board of Directors on August 6, 2026 1. Implementation of the free shares plan Pursuant to decisions dated June 25, 2026 the shareholders’ general meeting of Cellectis, a French société anonyme whose registered office is located at 8 rue de la Croix Jarry, 75013 Paris and whose identification number is 428 859 052 R.C.S. Paris (hereafter referred to as the "Company") authorized the Board of Directors to allocate free shares of the…
Read attachment ↗clls-ex99_1.htm · 6-K · 2026-08-06
Exhibit 99.1 PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the six-month period ended June 30, 2026, included herein, have been prepared in accordance with International Accounting Standard 34 (“IAS 34”) - Interim Financial Reporting as issued by the International Accounting Standards Board (“IASB”). The consolidated financial statements are presented in U.S. dollars. All references in this interim report to “$” and “U.S. dollars” mean U.S. dollars and all refe…
Read attachment ↗clls-ex99_1.htm · 6-K/A · 2026-06-26
Exhibit 99.1 Voting Results for the Combined General Meeting of Shareholders N° Resolution Results For Against Vote Whithhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum …
Read attachment ↗clls-ex99_1.htm · 6-K · 2026-06-25
Exhibit 99.1 Voting Results for the Combined General Meeting of Shareholders N° Resolution Results For Against Vote Whithhold Total votes Shares represented by the votes cast Percentage of the share capital represented by the votes cast Out of voting rights Null voting rights Quorum …
Read attachment ↗